Adverse drug events (ADEs) are a very real problem in the community, associated with 25-30% of hospital admissions in older adults and estimated to be the 4th or 5th leading cause [...]
Here’s an odd one! Who would have ever suspected an association between the use of the selective alpha-blocker tamsulosin (Flomax), used for men with enlarged prostate to inc[...]
The Food and Drug Administration again released a safety alert regarding the dosing of Celexa (citalopram) citing evidence that doses higher than 20mg in older adults can lead to a[...]
In the most recent issue (March 2012) of The Consultant Pharmacist, the journal of the American Society of Consulting Pharmacists, authors Christopher Novak, et al, published their[...]
The American Geriatrics Society just updated the Beers criteria, the list of medications that may be inappropriate for use in older adults. Many of the originally listed drugs rema[...]
I’ve posted for some time on the potential for some older adults to experience life-altering adverse effects from statins, such as Crestor (rosuvastatin), Zocor (simvastatin)[...]
I read the press release over a year ago on how Golden Living Centers will be transitioning its contracted, outsourced pharmacy consulting services in its long term care facilities[...]
In October of 2010, Dr. Doron Garfinkel published study results from the application of the Good Palliative-Geriatric Practice algorithm in community-dwelling older adults, showing[...]
Published in the British Journal of Clinical Pharmacology in 2006, this article written by A. Blenkinsopp and others, reviews the literature on patient-reported symptoms of suspect[...]
Accountable Care Organizations (ACOs) may want to look a little deeper as to why many of their hospital patients who recently discharged are coming back within 30-days. An article [...]
